Prosecution Insights
Prosecution Insights
Technology area: Medical Devices & Mechanical Engineering
2 pending office actions • 1 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Boehringer Technologies LP operates within the Medical Devices & Mechanical Engineering technology area. The company currently has 2 pending office actions. These actions are concentrated within 1 distinct art unit, which suggests that the company's current intellectual property filings are focused on a specific technical sub-field with consistent examination standards. This concentration simplifies the administrative oversight required for the portfolio.
The prosecution is handled by 2 distinct examiners. LEVY, BRANDON WILLIAM is the busiest examiner for this portfolio, managing 1 pending office action. This represents a portion of the 2 total pending actions. For the practitioner, the workload is split between the 2 distinct examiners, meaning that the outcomes are dependent on the decisions of multiple individuals despite the single art unit assignment.
The 1 distinct art unit provides a centralized environment for the 2 pending office actions. LEVY, BRANDON WILLIAM's role in 1 pending office action means that his specific interpretation of the Medical Devices & Mechanical Engineering field will be a factor in the company's success. This distribution across 2 distinct examiners ensures that the 2 total actions are subject to different perspectives within the same art unit.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LEVY, BRANDON WILLIAM | 1 | 62.7% | +46.3% |
| MCCORMACK, ERIN KATHLEEN | 1 | 8.6% | +50.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17730434 | GASTRIC SIZING SYSTEMS INCLUDING ILLUMINATING DEVICES AND METHODS OF BARIATRIC SURGERY USING THE SAME | MCCORMACK, ERIN KATHLEEN | 19d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17730434 | GASTRIC SIZING SYSTEMS INCLUDING ILLUMINATING DEVICES AND METHODS OF BARIATRIC SURGERY USING THE SAME | MCCORMACK, ERIN KATHLEEN | 19d |
| 19037702 | EXTERNAL FEMALE CATHETER SYSTEM AND METHOD OF USE | LEVY, BRANDON WILLIAM | — |
| Art Unit | Apps |
|---|---|
| 3791 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19037702 | EXTERNAL FEMALE CATHETER SYSTEM AND METHOD OF USE | LEVY, BRANDON WILLIAM | — | §103 | Non-Final OA | — | Pending | Jan 27, 2025 |
| 17730434 | GASTRIC SIZING SYSTEMS INCLUDING ILLUMINATING DEVICES AND METHODS OF BARIATRIC SURGERY USING THE SAME | MCCORMACK, ERIN KATHLEEN | 3791 | §103§112 | Non-Final OA | 19d | Pending | Apr 27, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial